The Registry of Toxic Effects of Chemical Substances
Acrylamide |
UPDATE: May 2005 | MW: 71.09 | MF: C3H5NO |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
10 mg/30S rinse
|
mild
|
TXAPA9 6,172,1964
|
eye | rabbit
100 mg/24 hour
|
moderate
|
28ZPAK -,54,1972
|
skin | rabbit
50 mg/3 day
|
mild
|
TXAPA9 6,172,1964
|
skin | rabbit
500 mg/24 hour
|
mild
|
85JCAE -,337,1986
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
lung
|
150 mg/L
|
ESKHA5 (103),64,1985
|
cytogenetic analysis
|
hamster
fibroblast
|
500 mg/L
|
MUREAV 245,191,1990
|
cytogenetic analysis
|
oral | mouse
500 ppm/2 week- intermittent
|
MUREAV 57,313,1978
|
cytogenetic analysis
|
mouse
lymphocyte
|
750 mg/L
|
ENMUDM 9,261,1987
|
cytogenetic analysis
|
intraperitoneal | mouse
100 mg/kg
|
MUREAV 209,91,1988
|
dominant lethal test
|
intraperitoneal | mouse
125 mg/kg
|
MUREAV 173,35,1986
|
dominant lethal test
|
oral | mouse
840 mg/kg/20 week- continuous
|
EMMUEG 17(Suppl 19),11,1991
|
dominant lethal test
|
oral | rat
150 mg/kg/5 day- continuous
|
MUTAEX 2,215,1987
|
DNA adduct
|
intraperitoneal | mouse
50 mg/kg
|
MUREAV 580,131,2005
|
DNA adduct
|
oral | mouse
3 mg/kg/3 day- intermittent
|
MUREAV 580,131,2005
|
DNA adduct
|
oral | mouse
50 mg/kg
|
MUREAV 580,131,2005
|
DNA adduct
|
oral | rat
18 mg/kg
|
MUREAV 580,119,2005
|
DNA adduct
|
oral | rat
3 mg/kg/3 day- intermittent
|
MUREAV 580,131,2005
|
DNA adduct
|
intraperitoneal | rat
50 mg/kg
|
MUREAV 580,131,2005
|
DNA damage
|
hamster
lung
|
6 mmol/L/24 hour
|
MUREAV 580,71,2005
|
DNA damage
|
human
other cell types
|
6 mmol/L/24 hour
|
MUREAV 580,71,2005
|
DNA damage
|
intraperitoneal | mouse
100 mg/kg
|
MUREAV 242,79,1990
|
DNA damage
|
oral | rat
36 mg/kg
|
MUREAV 580,119,2005
|
DNA inhibition
|
rat
other cell types
|
1 mmol/L
|
TIVIEQ 2,69,1988
|
unscheduled DNA synthesis
|
human
mammary gland
|
1 mmol/L
|
EMMUEG 20,148,1992
|
unscheduled DNA synthesis
|
intraperitoneal | mouse
62,500 µg/kg
|
EMMUEG 16,137,1990
|
unscheduled DNA synthesis
|
oral | rat
150 mg/kg/5 day- continuous
|
EMMUEG 20,148,1992
|
mutation in microorganisms
|
mouse
lymphocyte
|
300 mg/L (+enzymatic activation step)
|
MUTAEX 3,263,1988
|
micronucleus test
|
mouse
fibroblast
|
100 mg/L
|
MUTAEX 16,145,2001
|
micronucleus test
|
intraperitoneal | mouse
30 mg/kg
|
MUREAV 535,215,2003
|
micronucleus test
|
oral | mouse
200 mg/kg/4 day
|
EMMUEG 40,71,2002
|
micronucleus test
|
subcutaneous | mouse
50 mg/kg
|
MUREAV 580,111,2005
|
micronucleus test
|
intraperitoneal | rat
100 mg/kg
|
MUREAV 309,245,1994
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
500 mg/L
|
ENMUDM 9,261,1987
|
morphological transform
|
hamster
embryo
|
0.5 mmol/L/7 day
|
TOSCF2 65,177,2002
|
morphological transform
|
mouse
fibroblast
|
12,500 µg/L
|
CALEDQ 32,293,1986
|
morphological transform
|
mouse
embryo
|
25 mg/L
|
CALEDQ 32,293,1986
|
sister chromatid exchange
|
hamster
lung
|
300 mg/L
|
MUTAEX 3,263,1988
|
sister chromatid exchange
|
hamster
lung
|
200 µmol/L/32 hour
|
MUREAV 580,41,2005
|
sister chromatid exchange
|
intraperitoneal | mouse
125 µg/kg
|
EMMUEG 13,218,1989
|
sister chromatid exchange
|
oral | rat
600 mg/kg/10 day- continuous
|
ENMUDM 7(Suppl 3),79,1985
|
sex chromosome loss and nondisjunction
|
hamster
lung
|
500 mg/L
|
MUREAV 245,191,1990
|
sex chromosome loss and nondisjunction
|
intraperitoneal | mouse
120 mg/kg
|
MUREAV 367,195,1996
|
specific locus test
|
oral | Drosophila melanogaster
1 mmol/L
|
MUTAEX 3,263,1988
|
specific locus test
|
intraperitoneal | mouse
50 mg/kg
|
MUREAV 226,157,1989
|
specific locus test
|
intraperitoneal | mouse
175 mg/kg/7 day
|
MUREAV 540,141,2003
|
sperm morphology
|
intraperitoneal | mouse
100 mg/kg
|
MUREAV 57,313,1978
|
sperm morphology
|
oral | mouse
96,634 µg/kg/4 week- continuous
|
ARTODN 59,201,1986
|
heritable translocation test
|
intraperitoneal | mouse
50 mg/kg
|
MUREAV 309,285,1994
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic dose: 225 mg/kg (5 day male)
|
Reproductive: Other effects on male | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
REPTED 14,147,2000
|
inhalation | rat
lowest published toxic concentration: 300 ppm/6 hour (6-20 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOSCF2 48,240,1999
|
intraperitoneal | mammal (species unspecified)
lowest published toxic dose: 75 mg/kg (12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
MUREAV 226,157,1989
|
intraperitoneal | mammal (species unspecified)
lowest published toxic dose: 225 mg/kg (10-12 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death
MUREAV 226,157,1989
|
intraperitoneal | mouse
lowest published toxic dose: 225 mg/kg (10-12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
MUREAV 226,157,1989
|
intraperitoneal | mouse
lowest published toxic dose: 125 mg/kg (1 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
CGANE7 34,35,1994
|
intraperitoneal | mouse
lowest published toxic dose: 250 mg/kg (5 day male)
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
CGANE7 34,35,1994
|
intraperitoneal | mouse
lowest published toxic dose: 300 mg/kg (8-10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
CGANE7 34,35,1994
|
intraperitoneal | mouse
lowest published toxic dose: 125 mg/kg (1 day male)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
REPTED 17,1,2003
|
intraperitoneal | rat
lowest published toxic dose: 350 mg/kg (7 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
NRTXDN 13,219,1992
|
intraperitoneal | rat
lowest published toxic dose: 400 mg/kg (8 day male)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on newborn: Behavioral
NRTXDN 13,219,1992
|
oral | mouse
lowest published toxic dose: 571 mg/kg (16 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
ARTODN 47,179,1981
|
oral | mouse
lowest published toxic dose: 95 gm/kg (4 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
ARTODN 59,201,1986
|
oral | mouse
lowest published toxic dose: 95 gm/kg (4 week prior to copulation)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
ARTODN 59,201,1986
|
oral | mouse
lowest published toxic dose: 71 gm/kg (4 week male)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
|
ARTODN 59,201,1986
|
oral | mouse
lowest published toxic dose: 840 mg/kg (20 week male)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
EMMUEG 17,11,1991
|
oral | mouse
lowest published toxic dose: 3,462.48 mg/kg (189 day male/189 day prior to copulation)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
|
NTIS** PB93-158285
|
oral | mouse
lowest published toxic dose: 1,282.4 mg/kg (140 day male)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
NTIS** PB93-158285
|
oral | mouse
lowest published toxic dose: 2.39 mg/kg (multigenerations)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
NTIS** PB93-158285
|
oral | mouse
lowest published toxic dose: 540 mg/kg (6-17 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
NTIS** #PB89-140008/AS
|
oral | mouse
lowest published toxic dose: 180 mg/kg (6-17 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
NTIS** #PB89-140008/AS
|
oral | mouse
lowest published toxic dose: 308 mg/kg (1 week male/1 week prior to copulation/21 day pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
|
REPTED 17,1,2003
|
oral | mouse
lowest published toxic dose: 8.8 mg/kg (multigenerations)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
|
REPTED 17,1,2003
|
oral | mouse
lowest published toxic dose: 8.8 mg/kg (multigenerations)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system | Reproductive: Specific developmental abnormalities: Urogenital system
REPTED 17,1,2003
|
oral | mouse
lowest published toxic dose: 862.4 mg/kg (98 day male)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 17,1,2003
|
oral | mouse
lowest published toxic dose: 862.4 mg/kg (98 day prior to copulation)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles) | Reproductive: Effects on fertility: Other measures of fertility
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 200 mg/kg (7-16 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
TOLED5 7,233,1981
|
oral | rat
lowest published toxic dose: 560 mg/kg (6-21 day pregnant/10 day after birth)
|
Reproductive: Maternal effects: Parturition | Reproductive: Effects on newborn: Stillbirth Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
NETEEC 17,189,1995
|
oral | rat
lowest published toxic dose: 75 mg/kg (5 day male)
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
|
TJADAB 35,37A,1987
|
oral | rat
lowest published toxic dose: 140 mg/kg (2 week prior to copulation-3 week after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
JTEHD6 17,457,1986
|
oral | rat
lowest published toxic dose: 150 mg/kg (5 day male)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
MUTAEX 2,215,1987
|
oral | rat
lowest published toxic dose: 225 mg/kg (5 day male)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetal death
REPTED 14,147,2000
|
oral | rat
lowest published toxic dose: 945 mg/kg (70 day male/70 day prior to copulation-4 week after birth)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 945 mg/kg (70 day male/70 day prior to copulation-4 week after birth)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Behavioral
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 378 mg/kg (70 day male/70 day prior to copulation-4 week after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Delayed effects
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 945 mg/kg (multigeneration))
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 945 mg/kg (multigeneration))
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Delayed effects
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 35 mg/kg (70 day male/70 day prior to copulation)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
|
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 700 mg/kg (10 week male/10 week prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated)
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 810 mg/kg (10 week male/10 week prior to copulation/22 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 2 mg/kg (multigenerations)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 5 mg/kg (multigenerations)
|
Reproductive: Other developmental abnormalities
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 5 mg/kg (multigenerations)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 2 mg/kg (multigenerations)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 350 mg/kg (10 week male)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 700 mg/kg (56 day male)
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 700 mg/kg (56 day prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 560 mg/kg (2 week prior to copulation/21 day pregnant/21 after birth)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) | Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 280 mg/kg (2 week prior to copulation/21 day pregnant/21 after birth)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles)
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 336 mg/kg (4 week male)
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 35 mg/kg (4 week male)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 70 mg/kg (4 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
REPTED 17,1,2003
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 24 mg/kg/8 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
CNREA8 44,107,1984
|
intraperitoneal | mouse
toxic dose : 72 mg/kg/8 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
CNREA8 44,107,1984
|
oral | mouse
lowest published toxic dose: 300 mg/kg/2 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors
CALEDQ 24,209,1984
|
oral | rat
lowest published toxic dose: 1,456 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Reproductive: Tumorigenic effects: Testicular tumors
TXAPA9 85,154,1986
|
oral | rat
toxic dose : 1,456 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Reproductive: Tumorigenic effects: Uterine tumors
TXAPA9 85,154,1986
|
oral | rat
toxic dose : 1,460 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors Skin and Appendages: Tumors
NTIS** OTS0555720
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 170 mg/kg
|
N/R
|
TXAPA9 33,142,1975
|
intraperitoneal | rat
lethal dose (50 percent kill): 90 mg/kg
|
N/R
|
AMPMAR 36,58,1975
|
intravenous | mammal (species unspecified)
lowest published lethal dose: 190 mg/kg
|
N/R
|
COREAF 153,895,1911
|
oral | guinea pig
lethal dose (50 percent kill): 150 mg/kg
|
N/R
|
TXAPA9 6,172,1964
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 100 mg/kg
|
N/R
|
KASEAA 17,495,1979
|
oral | mouse
lethal dose (50 percent kill): 107 mg/kg
|
N/R
|
ARTODN 47,179,1981
|
oral | quail
lethal dose (50 percent kill): 186 mg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Altered sleep time (including change in righting reflex) Behavioral: Change in motor activity (specific assay)
JTEHD6 7,935,1981
|
oral | rat
lethal dose (50 percent kill): 124 mg/kg
|
N/R
|
AMPMAR 36,58,1975
|
oral | rat
lowest published toxic dose: 50 mg/kg
|
Blood: Other changes
|
TOXID9 72(Suppl 1),248,2003
|
oral | rat
lowest published toxic dose: 50 mg/kg
|
Blood: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TOSCF2 71,164,2003
|
oral | rabbit
lethal dose (50 percent kill): 150 mg/kg
|
N/R
|
TXAPA9 6,172,1964
|
subcutaneous | guinea pig
lethal dose (50 percent kill): 170 mg/kg
|
Behavioral: Tremor | Behavioral: Muscle contraction or spasticity Gastrointestinal: Nausea or vomiting
MELAAD 47,192,1956
|
skin | rat
lethal dose (50 percent kill): 400 mg/kg
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Peptidases
GISAAA 44(10),73,1979
|
skin | rabbit
lethal dose (50 percent kill): 1,680 µL/kg
|
Behavioral: Hallucinations, distorted perceptions
|
ATDAEI 1,115,1990
|
unreported route | guinea pig
lethal dose (50 percent kill): 173 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Behavioral: Change in motor activity (specific assay)
GISAAA 43(9),38,1978
|
unreported route | mouse
lethal dose (50 percent kill): 156 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Behavioral: Change in motor activity (specific assay)
GISAAA 43(9),38,1978
|
unreported route | rat
lethal dose (50 percent kill): 208 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Behavioral: Change in motor activity (specific assay)
GISAAA 43(9),38,1978
|
unreported route | rabbit
lethal dose (50 percent kill): 280 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Behavioral: Change in motor activity (specific assay)
GISAAA 43(9),38,1978
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | cat
lowest published toxic dose: 300 mg/kg/10 day- intermittent
|
Spinal Cord: Other degenerative changes | Behavioral: Muscle weakness
TXAPA9 88,175,1987
|
intraperitoneal | monkey
lowest published toxic dose: 200 mg/kg/2 day- intermittent
|
Lung, Thorax, or Respiration: Chronic pulmonary edema or congestion | Liver: Fatty liver degeneration Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 6,172,1964
|
intraperitoneal | mouse
lowest published toxic dose: 1,200 mg/kg/4 week- intermittent
|
Behavioral: Muscle weakness | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 63,470,1982
|
intraperitoneal | mouse
lowest published toxic dose: 400 mg/kg/8 day- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Change in motor activity (specific assay) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
NEZAAQ 50,292,1995
|
intraperitoneal | rat
lowest published toxic dose: 108 mg/kg/3 week- intermittent
|
Brain and Coverings: Other degenerative changes | Spinal Cord: Other degenerative changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
NETEEC 14,273,1992
|
intraperitoneal | rat
lowest published toxic dose: 168 mg/kg/2 week- continuous
|
Behavioral: Muscle weakness
|
TXAPA9 40,589,1977
|
intraperitoneal | rat
lowest published toxic dose: 780 mg/kg/13 week- intermittent
|
Spinal Cord: Demyelination | Peripheral Nerve and Sensation: Structural change in nerve or sheath Behavioral: Ataxia
FAATDF 18,343,1992
|
intraperitoneal | rat
lowest published toxic dose: 400 mg/kg/8 day- intermittent
|
Brain and Coverings: Other degenerative changes | Spinal Cord: Other degenerative changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
ENVRAL 61,37,1993
|
intraperitoneal | rat
lowest published toxic dose: 120 mg/kg/12 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
WDZAEK 6,71,1992
|
intraperitoneal | rat
lowest published toxic dose: 550 mg/kg/11 day- intermittent
|
Behavioral: Ataxia | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
NRTXDN 22,341,2001
|
intraperitoneal | rat
lowest published toxic dose: 300 mg/kg/2 week- intermittent
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Behavioral: Muscle weakness Biochemical: Metabolism (intermediary): Other
NETEEC 22,247,2000
|
intraperitoneal | rat
lowest published toxic dose: 400 mg/kg/8 day- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,95,2002
|
intraperitoneal | rat
lowest published toxic dose: 250 mg/kg/5 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
NRTXDN 23,397,2002
|
intraperitoneal | rat
lowest published toxic dose: 550 mg/kg/11 day- intermittent
|
Behavioral: Ataxia | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,397,2002
|
intraperitoneal | rat
lowest published toxic dose: 550 mg/kg/11 day- intermittent
|
Brain and Coverings: Other degenerative changes | Spinal Cord: Other degenerative changes Behavioral: Ataxia
TXAPA9 188,135,2003
|
intraperitoneal | rat
lowest published toxic dose: 400 mg/kg/8 day- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Ataxia
NRTXDN 23,397,2002
|
intraperitoneal | rat
lowest published toxic dose: 550 mg/kg/11 day- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,397,2002
|
intraperitoneal | rat
lowest published toxic dose: 250 mg/kg/5 day- intermittent
|
Spinal Cord: Other degenerative changes
|
NRTXDN 23,415,2002
|
intraperitoneal | rat
lowest published toxic dose: 400 mg/kg/8 day- intermittent
|
Spinal Cord: Other degenerative changes | Behavioral: Ataxia
NRTXDN 23,415,2002
|
intraperitoneal | rat
lowest published toxic dose: 550 mg/kg/11 day- intermittent
|
Spinal Cord: Other degenerative changes | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,415,2002
|
intraperitoneal | rat
lowest published toxic dose: 250 mg/kg/5 day- intermittent
|
Behavioral: Ataxia | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,95,2002
|
intraperitoneal | rat
lowest published toxic dose: 400 mg/kg/8 day- intermittent
|
Behavioral: Muscle weakness
|
NRTXDN 23,95,2002
|
intravenous | monkey
lowest published toxic dose: 200 mg/kg/4 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TXAPA9 6,172,1964
|
oral | cat
lowest published toxic dose: 771 mg/kg/1 year- intermittent
|
Behavioral: Muscle weakness
|
TXAPA9 6,172,1964
|
oral | chicken
lowest published toxic dose: 450 mg/kg/3 week- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia
BJIMAG 32,31,1975
|
oral | dog
lowest published toxic dose: 330 mg/kg/22 day- intermittent
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Behavioral: Muscle weakness Behavioral: Ataxia
ARZNAD 23,1566,1973
|
oral | dog
lowest published toxic dose: 392 mg/kg/8 week- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia Gastrointestinal: Nausea or vomiting
JNNPAU 44,906,1981
|
oral | monkey
lowest published toxic dose: 671 mg/kg/75 week- intermittent
|
Autonomic Nervous System: Other (direct) parasympathomimetic | Behavioral: Change in motor activity (specific assay) Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 6,172,1964
|
oral | monkey
lowest published toxic dose: 450 mg/kg/61 day- intermittent
|
Peripheral Nerve and Sensation: Sensory change involving peripheral nerve
|
TXAPA9 71,266,1983
|
oral | mouse
lowest published toxic dose: 568 mg/kg/8 week- intermittent
|
Related to Chronic Data: Changes in testicular weight
|
ARTODN 47,179,1981
|
oral | mouse
lowest published toxic dose: 5.04 mg/kg/1 week- continuous
|
Behavioral: Fluid intake
|
NTIS** PB93-158285
|
oral | mouse
lowest published toxic dose: 451.71 mg/kg/27 week- continuous
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
NTIS** PB93-158285
|
oral | mouse
lowest published toxic dose: 105 mg/kg/3 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Behavioral: Change in motor activity (specific assay)
TOLED5 135,S52,2002
|
oral | mouse
lowest published toxic dose: 210 mg/kg/3 week- intermittent
|
Behavioral: Muscle weakness | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TOLED5 135,S52,2002
|
oral | mouse
lowest published toxic dose: 540 mg/kg/12 day- intermittent
|
Behavioral: Muscle weakness | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NTIS** #PB89-140008/AS
|
oral | mouse
lowest published toxic dose: 238 mg/kg/17 week- continuous
|
Behavioral: Muscle weakness
|
REPTED 17,1,2003
|
oral | mouse
lowest published toxic dose: 238 mg/kg/17 week- continuous
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 1,035 mg/kg/15 week- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NTOTDY 5,91,1983
|
oral | rat
lowest published toxic dose: 608 mg/kg/16 day- continuous
|
Spinal Cord: Other degenerative changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NTOTDY 3,487,1981
|
oral | rat
lowest published toxic dose: 1,800 mg/kg/90 day- continuous
|
Peripheral Nerve and Sensation: Structural change in nerve or sheath | Behavioral: Fluid intake Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JEPTDQ 4(5/6),157,1980
|
oral | rat
lowest published toxic dose: 600 mg/kg/6 week- continuous
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Ataxia
NTOTDY 4,355,1982
|
oral | rat
lowest published toxic dose: 286 mg/kg/28 day- continuous
|
Brain and Coverings: Changes in brain weight | Cardiac: Changes in heart weight Blood: Pigmented or nucleated red blood cells
WATRAG 24,661,1990
|
oral | rat
lowest published toxic dose: 680 mg/kg/34 day- continuous
|
Behavioral: Ataxia | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
NRTXDN 22,341,2001
|
oral | rat
lowest published toxic dose: 75 mg/kg/5 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
REPTED 14,147,2000
|
oral | rat
lowest published toxic dose: 225 mg/kg/5 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
REPTED 14,147,2000
|
oral | rat
lowest published toxic dose: 300 mg/kg/5 day- intermittent
|
Behavioral: Sleep | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
REPTED 14,147,2000
|
oral | rat
lowest published toxic dose: 56 mg/kg/28 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 28 mg/kg/14 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 84 mg/kg/42 day- continuous
|
Behavioral: Food intake (animal)
|
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 3.5 mg/kg/70 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Behavioral: Change in motor activity (specific assay)
REPTED 14,385,2000
|
oral | rat
lowest published toxic dose: 112.5 mg/kg/15 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NTIS** #PB89-164669/AS
|
oral | rat
lowest published toxic dose: 546 mg/kg/26 day- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,95,2002
|
oral | rat
lowest published toxic dose: 294 mg/kg/14 day- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Ataxia
NRTXDN 23,397,2002
|
oral | rat
lowest published toxic dose: 798 mg/kg/38 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NRTXDN 23,397,2002
|
oral | rat
lowest published toxic dose: 21 mg/kg/4 week- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 21 mg/kg/4 week- continuous
|
Brain and Coverings: Other degenerative changes
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 460 mg/kg/92 day- continuous
|
Brain and Coverings: Other degenerative changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 560 mg/kg/56 day- continuous
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage)
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 280 mg/kg/56 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 336 mg/kg/4 week- continuous
|
Behavioral: Muscle weakness
|
REPTED 17,1,2003
|
oral | rat
lowest published toxic dose: 597.2 mg/kg/10 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JESEDU A22,639,1987
|
oral | rat
lowest published toxic dose: 298.6 mg/kg/10 day- intermittent
|
Liver: Changes in liver weight
|
JESEDU A22,639,1987
|
oral | rat
lowest published toxic dose: 588 mg/kg/28 day- intermittent
|
Brain and Coverings: Other degenerative changes | Spinal Cord: Other degenerative changes Behavioral: Ataxia
TXAPA9 188,135,2003
|
oral | rat
lowest published toxic dose: 294 mg/kg/14 day- continuous
|
Brain and Coverings: Other degenerative changes | Behavioral: Ataxia
NRTXDN 23,397,2002
|
oral | rat
lowest published toxic dose: 798 mg/kg/38 day- continuous
|
Brain and Coverings: Other degenerative changes | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,397,2002
|
oral | rat
lowest published toxic dose: 588 mg/kg/28 day- continuous
|
Spinal Cord: Other degenerative changes | Behavioral: Ataxia
NRTXDN 23,415,2002
|
oral | rat
lowest published toxic dose: 798 mg/kg/38 day- continuous
|
Spinal Cord: Other degenerative changes | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,415,2002
|
oral | rat
lowest published toxic dose: 231 mg/kg/11 day- continuous
|
Behavioral: Ataxia | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 23,95,2002
|
oral | rat
lowest published toxic dose: 378 mg/kg/18 day- continuous
|
Behavioral: Muscle weakness
|
NRTXDN 23,95,2002
|
subcutaneous | cat
lowest published toxic dose: 150 mg/kg/10 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TXAPA9 60,324,1981
|
subcutaneous | rat
lowest published toxic dose: 1,155 mg/kg/13 week- intermittent
|
Peripheral Nerve and Sensation: Sensory change involving peripheral nerve | Peripheral Nerve and Sensation: Recording from peripheral motor nerve Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ENVRAL 63,229,1993
|
subcutaneous | rat
lowest published toxic dose: 1 gm/kg/8 week- intermittent
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Peripheral Nerve and Sensation: Structural change in nerve or sheath
TXAPA9 139,15,1996
|
subcutaneous | rat
lowest published toxic dose: 400 mg/kg/10 day- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JOCHFV 41,181,1999
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.03 mg/m3 (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 39,41,1986
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 60,389,1994
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 39,41,1986
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 60,389,1994
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2A
|
IMEMDT 60,389,1994
|
TOXICOLOGY REVIEW
|
|
NRTXDN 23,265,2002
|
TOXICOLOGY REVIEW
|
|
NRTXDN 23,259,2002
|
TOXICOLOGY REVIEW
|
|
NRTXDN 23,253,2002
|
TOXICOLOGY REVIEW
|
|
NRTXDN 23,43,2002
|
TOXICOLOGY REVIEW
|
|
NRTXDN 23,223,2002
|
TOXICOLOGY REVIEW
|
|
NTOTDY 3,445,1981
|
TOXICOLOGY REVIEW
|
|
TOPADD 14,279,2001
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,43,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 5432012003
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 580,21,2005
|
TOXICOLOGY REVIEW
|
|
MUREAV 580,143,2005
|
TOXICOLOGY REVIEW
|
|
MUREAV 580,167,2005
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.3 mg/m3 (skin)
|
DTLVS* 3,5,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 0.3 mg/m3 (skin)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 0.3 mg/m3 (skin)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 0.3 mg/m3 (skin)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 0.3 mg/m3 (skin)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.3 mg/m3, Skin, Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.3 mg/m3, Skin, Carcinogen JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.03 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.3 mg/m3, short term exposure limit 0.9 mg/m3, JAN1993
|
Occupational Exposure Limit - FRANCE
|
VME 0.1 ppm (0.3 mg/m3), Skin, continuous2 Carcinogen, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - HUNGARY
|
short term exposure limit 0.3 mg/m3, Skin, Carcinogen, JAN1993
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 0.3 mg/m3, Skin, 2A Carcinogen, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.3 mg/m3, JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 0.3 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - POLAND
|
time-weighted average 0.1 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.2 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 0.03 mg/m3, KTV 0.1 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.03 mg/m3, Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.3 mg/m3, Skin, Carcinogen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Animal Carcinogen with Unknown
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Animal Carcinogen with Unknown |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ACRYLAMIDE-air
|
Carcinogen; | 10 hour time-weighted average 0.03 mg/m3 (Sk)
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 03540; | Number of Industries 10; Total Number of Facilities 442; Number of Occupations 24; Total Number of Employees Exposed 7,047
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 03540; |
Number of Industries 19; Total Number of Facilities 453; Number of Occupations 22; Total Number of Employees Exposed 10,651; Total Number of Female Employees Exposed 721 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Cytogenetics-male germ cell
|
EPA GENETOX PROGRAM 1988, Negative: In vivo cytogenetics-nonhuman bone marrow
|
EPA GENETOX PROGRAM 1988, Inconclusive: In vivo SCE-nonhuman
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE
|
FEREAC 47,26992,82
|
Used in the manufacture of plastics, resins, rubber, synthetic textiles, as a dye, pigment
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NTP 10th Report on Carcinogens,2002:Reasonably anticipated to be a human carcinogen
|
OSHA ANALYTICAL METHOD #21
|
|
REFERENCES:
CODEN
|
|
REFERENCE
28ZPAK
|
"Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro
Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972
|
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
AMPMAR
|
Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF,
B.P.22, F-41353 Vineuil, France) V.7- 1946-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
ATDAEI
|
Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert,
Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990-
|
BJIMAG
|
British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME
04046) V.1- 1944-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CGANE7
|
Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589
Japan) V.27- 1987-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
COREAF
|
Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261,
1835-1965. For publisher information, see CRASEV.
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JESEDU
|
Journal of Environmental Science and Health, Part A: Environmental Science and Engineering.
(Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.A11- 1976-
|
JNNPAU
|
Journal of Neurology, Neurosurgery and Psychiatry. (British Medical Journal, POB 560B,
Kennebunkport, ME 04046) V.7- 1944-
|
JOCHFV
|
Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku,
Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
KASEAA
|
Kagaku to Seibutsu. Chemistry and Biology. (Gakkai Shuppan Senta, 6-2-10 Hongo, Bunkyo-ku,
Tokyo 113, Japan) V.1- 1962-
|
MELAAD
|
Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16-
1925-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NETEEC
|
Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.9- 1987-
|
NEZAAQ
|
Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto
Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
NTOTDY
|
Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher
information, see NETEEC.
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
TIVIEQ
|
Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523)
V.1- 1987-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOPADD
|
Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical
Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
WATRAG
|
Water Research. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1967-
|
WDZAEK
|
Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu,
Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987
|
|